EMEA Cell Counting Market 2018: Topmost Key Players Tecan Trading AG, BioTek Instruments, Thermo Fisher Scientific Inc. and More Future Outlook 2023

EMEA Cell Counting Market Research Report: By Product (Spectrophotometers, Flow Cytometers, Microplates) Application (Hematologic, Microbiology) By End Users (Hospitals & Clinics, Research Organizations, Academic Institutes) – Regional Forecast till 2023

The EMEA cell counting market is expected to grow at an approximate CAGR of 8.6% during the forecast period.

KEY PLAYERS FOR EMEA CELL COUNTING MARKET

Bio-Rad Laboratories Inc. (U.S.), General Electric Company (U.S.), Agilent Technologies (U.S.), PerkinElmer Inc. (U.S.), Tecan Trading AG (Switzerland), BioTek Instruments, Inc. (U.S.), Danaher (U.S.), and Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), and others are some of the key players for the EMEA cell counting market.

Get Sample Report @ https://www.marketresearchfuture.com/sample_request/603 .

MARKET SCENARIO FOR EMEA CELL COUNTING MARKET

Cell counting is used for the quantification of cells in life sciences. Cell counting is important for research and serves as one of the major steps in a majority of experiments. It is effectively utilized for maintaining cell cultures. Moreover, another important application of cell counting can be seen in the diagnosis of chronic diseases like cancer. For instance, increase in the number of white blood cells (WBC) may indicate the possibility of cancerous growth in the body. Thus, cell counting is important for microbiology, hematologic and other medical specialties. Rising prevalence of chronic diseases like cancer, TB (tuberculosis), AIDS along with increasing healthcare sector is driving the growth of this market. According to the World Health Organization, cancer was the second leading cause of death across the globe in 2015 and caused around 8.8 million deaths globally. Moreover, it was estimated that more than 70% of the deaths due to cancer was caused in the middle and low-income countries. Moreover, increasing biotechnology industries and growing pharmaceutical sector is fuelling the market growth during the forecast period. In 2017, according to the Biotechnology and Biological Sciences Research Council (BBSRC), the European industrial biotechnology industry is expected to reach approximately USD 53.2 billion by 2030 from 28 billion in 2013. However, lack of skilled professionals and the high cost of the cell counting equipment may restrain the market growth during the forecast period, 2017-2023.

SEGMENTATION FOR EMEA CELL COUNTING MARKET

The EMEA cell counting market is segmented on the basis of product, application, and end users.

On the basis of the product, the market is segmented into instruments, consumables & accessories, and others. The instrument segment is sub-segmented into spectrophotometers, flow cytometers, hematology analyzers, cell counters, and others. The consumables & accessories segment is sub-segmented into reagents, microplates, and others.

On the basis of the application, the market is segmented into hematology, microbiology, and others.

On the basis of the end users, the market is segmented into hospitals & clinics, research organizations, academic institutes, and others.

REGIONAL ANALYSIS FOR EMEA CELL COUNTING MARKET

Europe is the largest EMEA cell counting market. Rising government support for research and a well-developed healthcare infrastructure within the region is driving the market growth within the region. This along with a huge patient population and growing healthcare expenditure is fuelling the market growth. According to the Cancer Research UK in 2014, about 356,860 new cases of cancer were reported within the region. Moreover, the total estimated deaths due to the same in 2014 were about 163,444.

Asia Pacific is the fastest growing region in the EMEA cell counting market. Presence of a huge patient population and continuously developing economies like India and China within the region drive the market growth. According to the Indian Brand Equity Foundation in 2017, the Indian healthcare sector is one of the fastest growing industries and is expected to advance at a CAGR of 22.8% and reach USD 280 billion by 2020. Moreover, according to the National Institute of Cancer Prevention and Research in 2017, about 2.5 million people are living with cancer. Additionally, favorable government policies like reduced excise and customs duty followed by the exemptions in service tax boost the market growth. Additionally, increasing healthcare expenditures fuels the market within the region.

Get Discount @ https://www.marketresearchfuture.com/check-discount/603 .

MAJOR TOC FOR EMEA Cell Counting Market

CHAPTER 1. REPORT PROLOGUE

CHAPTER 2. MARKET INTRODUCTION

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

CHAPTER 3. RESEARCH METHODOLOGY

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

CHAPTER 4. MARKET DYNAMICS

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

CHAPTER 5. MARKET FACTOR ANALYSIS

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

TOC Continued….

Inquire before Buying @ https://www.marketresearchfuture.com/enquiry/603 .

About Us:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future, Office No. 528,
Amanora Chambers Magarpatta Road,
Hadapsar, Pune - 411028 Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.